US$ 26.47
glp-1 drugs pharmaceutical companies news 2025 health pharma today obesity october Outlook for obesity in 2025: more GLP-1 Shortage = Over -
Description
Obesity is more prevalent among low-income Rhode Islanders and communities of color

The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease
Hermansen K, Kipnes M, Luo E, et al

Clinical trials have revealed that retatrutide can reduce markers of inflammation, such as C-reactive protein (CRP), which are associated with an increased risk of cardiovascular disease

Gut microbiotabrain axis in depression: the role of neuroinflammation
